MarkD.OkusaMD

John C. Buchanan Distinguished Professor of Medicine, University of Virginia School of Medicine

Dr. Okusa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1300 Jefferson Park Ave
Fl 5
Charlottesville, VA 22903
Phone+1 434-924-2187

Fax+1 434-243-6284

Dr. Mark Okusa is a nephrologist in Charlottesville, VA and is affiliated with multiple hospitals in the area, including Augusta Health and University of Virginia Medical Center. He received his medical degree from Virginia Commonwealth University School of Medicine and has been in practice 35 years. He is experienced in hypertension, general nephrology, acute renal failure, acute interstitial nephritis, and transplant nephrology.

Yale-New Haven Medical CenterFellowship, Nephrology, 1986 - 1987
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1982 - 1985
Virginia Commonwealth University School of MedicineClass of 1982

America's Top Doctors Castle Connolly, 2002-2022
C. Crait Tischer Lecturer University of Florida, 2019
Best Doctors in America 2005-2019
President American Society of Nephrology, 2018
Elected member Association of American Physicians, 2018
Robert Berliner Lecturer Yale University, 2018
Elected Councilor American Society of Nephrology, 2012
Elected Member American Clinical and Climatological Association, 2011
Elected Alpha Omega Alpha Medical College of Virginia/Virginia Commonwealth University, 2009
Fellow (FASN) American Society of Nephrology, 2004
Join now to see all

Optimizing Ultrasound-induced Anti-inflammation in Human Subjects Start of enrollment: 2022 Dec 01
Recruiting
Not Applicable
Roles: Principal Investigator

PubMed

48 citations
Targeting of Adenosine Receptors in Ischemia-Reperfusion Injury
Victor E. Laubach, Brent A. French, Mark D. Okusa
Expert Opinion on Therapeutic Targets. 2011-01-01
747 citations
Acute Kidney Injury Associated with Cardiac Surgery
Mitchell H. Rosner, Mark D. Okusa
Clinical Journal of the American Society of Nephrology. 2005-10-19
284 citations
Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference
Patrick T. Murray, Ravindra L. Mehta, Andrew D. Shaw, Claudio Ronco, Zoltan H. Endre
Kidney International. 2014-03-01

Other

Epithelial and Endothelial Pannexin1 Channels Mediate AKI
Mark Okusa, MD, Journal of the American Society of Nephrology
https://www.doximity.com/articles/2c3abea7-e489-4c2a-9a08-0222fe66e1a6
UpToDate, Wolters Kluwer Health - 2013-03-04
Epithelial and Endothelial Pannexin1 Channels Mediate AKI
Mark Okusa, MD, Journal of the American Society of Nephrology
https://www.doximity.com/articles/2c3abea7-e489-4c2a-9a08-0222fe66e1a6
UpToDate, Wolters Kluwer Health - 2013-01-09
Epithelial and Endothelial Pannexin1 Channels Mediate AKI
Mark Okusa, MD, Journal of the American Society of Nephrology
https://www.doximity.com/articles/2c3abea7-e489-4c2a-9a08-0222fe66e1a6
UpToDate, Wolters Kluwer Health - 2012-09-06
Epithelial and Endothelial Pannexin1 Channels Mediate AKI
Mark Okusa, MD, Journal of the American Society of Nephrology
https://www.doximity.com/articles/2c3abea7-e489-4c2a-9a08-0222fe66e1a6
UpToDate, Wolters Kluwer Health - 2012-02-27
Epithelial and Endothelial Pannexin1 Channels Mediate AKI
Mark Okusa, MD, Journal of the American Society of Nephrology
https://www.doximity.com/articles/2c3abea7-e489-4c2a-9a08-0222fe66e1a6
UpToDate, Wolters Kluwer Health - 2013-03-18
Epithelial and Endothelial Pannexin1 Channels Mediate AKI
Mark Okusa, MD, Journal of the American Society of Nephrology
https://www.doximity.com/articles/2c3abea7-e489-4c2a-9a08-0222fe66e1a6
UpToDate, Wolters Kluwer Health - 2013-03-04
Join now to see all

Are You Part of the 90% Who Don’t Know They Have Chronic Kidney Disease?March 30th, 2023
Webster Santos Brings Molecule Inhibitor Discovery in Chronic Kidney Disease Closer to Drug TreatmentAugust 19th, 2022
High School Students Look to SOAR with Help of New UVA ProgramJuly 27th, 2021
Join now to see all

Kidney Disease and InflammationNIH/NIDDK2006–2021
Sphingolipids in Acute Kidney Injury and Disease ProgressionNIH/NIDDK2015–2020
Ultrasound for Non-Invasive Prevention of Acute Kidney InjuryNIH/NIDDK2015–2020
Nanotherapeutics For Acute Kidney InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases2012
Sphingolipids In Acute Kidney InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
Naturally Occurring IGM Anti-Leucocyte Autoantibodies Protect Against Renal IriNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
Kidney Disease And InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2011
Leukocyte Trafficking In Acute Renal FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2011
MBF Bioscience And Zeiss Microscope System For Stereology And Tissue MorphologyNational Center For Research Resources2010
Adenosine And Renal InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2009
Core--Inflammatory AssayNational Heart, Lung, And Blood Institute2004–2008
Lysophosphatidic Acid Receptors And Acute Renal FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
Novel Adenosine 2A Agonists In Renal Tissue ProtectionNational Institute Of Diabetes And Digestive And Kidney Diseases2000
SC 58535 BID And Naproxen BID On Renal Function And Urinary ProstaglandinsNational Center For Research Resources1998–1999